Filing Details
- Accession Number:
- 0000950170-24-041787
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-04 16:00:05
- Reporting Period:
- 2024-04-02
- Accepted Time:
- 2024-04-04 16:00:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527599 | Synlogic Inc. | SYBX | Pharmaceutical Preparations (2834) | 261824804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1820122 | Antoine Awad | C/O Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-04-02 | 372 | $1.73 | 33,859 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person on April 2, 2024 to cover the tax liability in connection with the vesting of three restricted stock awards, vesting on April 1, 2024, that were granted in 2020, 2021 and 2022.
Billionaire Hedge Funds
